Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

InMed Pharmaceuticals Inc. (INM) > Segments

BayMedica

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-K10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues  2.31.00.30.50.30.3  
            Revenue growth  349.0%234.0%      
Gross profit  1.30.20.30.20.20.3  
            Gross margin  56.4%18.6%100.0%48.5%58.9%100.0%  
EBIT  0.9-0.4-1.2-3.9-0.50.9  
            EBIT margin  39.3%-37.8%-387.0%-764.8%-172.7%339.5%  
   
Revenue Mix  62.9%100.0%100.0%100.0%100.0%100.0%  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy